PFO Device Evolution: Do We Need to Reduce the Anatomical Footprint?

Within the past 12 months, I or my spouse/partner have had a financial interest/arrangement or affiliation with the organization(s) listed below:

• Study honoraria to institution, travel expenses, consulting fees (Relationships with industry are limited to reimbursement for clinical trials. Personal honoraria had not been paid) (Institutional) - 4tech Cardio, Abbott, Ablative Solutions, Ancora Heart, Append Medical, Axon, Bavaria Medizin Technologie GmbH, Bioventrix, Boston Scientific, Carag, Cardiac Dimensions, Cardiac Success, Cardimed, Celonova, Contego, Coramaze, Croivalve, CVRx, Dinova, Edwa; Hangzhou Nuomao Medtech, Holistick Medical, Intershunt, K2, Lifetech, Magenta, Maquet Getinge Group, Medtronic, Metavention, Mitralix, Mokita, NXT Biomedical, Occlutech, Recor, Renal Guard, Terumo, Trisol, Vascular Dynamics, Vectorious Medtech, Venus, Ven